✦ LIBER ✦

Comparison of the anticoagulant intensities of fondaparinux and enoxaparin in the organization to assess strategies in acute ischemic syndromes (OASIS)-5 trial

✍ Scribed by J. A. M. ANDERSON; J. HIRSH; S. YUSUF; M. JOHNSTON; R. AFZAL; S. R. MEHTA; K. A. A. FOX; A. BUDAJ; J. W. EIKELBOOM

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Fondaparinux versus Enoxaparin in non–ST

✍ Mark J. Sculpher; Greta Lozano-Ortega; Jennifer Sambrook; Stephen Palmer; Orges 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 225 KB

Efficacy and Safety of Fondaparinux Vers

✍ Sanjit S. Jolly; David P. Faxon; Keith A.A. Fox; Rizwan Afzal; William E. Boden; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 847 KB

Design and rationale of the MICHELANGELO

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 758 KB

Design, baseline characteristics, and pr

✍ Salim Yusuf 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 129 KB

Efficacy and Safety of Fondaparinux Vers

✍ Shamir R. Mehta; Christopher B. Granger; John W. Eikelboom; Jean-Pierre Bassand; 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 609 KB

The organization to assess strategies fo

✍ Sonia S Anand 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 191 KB